Nobuko Matsushima
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi-Regional Clinical Trials and Future Pathways.
Journal: Clinical pharmacology and therapeutics
Published: March 19, 2026
Pharmacokinetics and Pharmacodynamics of Nipocalimab, a Neonatal Fc Receptor Blocker, in Healthy Japanese Volunteers.
Journal: Clinical drug investigation
Published: June 30, 2024
Summary Report of a Public Workshop: Case Studies of Multi-Regional Clinical Trial Incorporating Concept of the ICH E17 Guideline.
Journal: Clinical pharmacology and therapeutics
Published: August 08, 2023
Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease.
Journal: Journal of personalized medicine
Published: January 28, 2022
A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies.
Journal: Journal of personalized medicine
Published: January 26, 2022
Pharmacokinetics and safety of rilpivirine in healthy Japanese subjects and exploration of ethnic sensitivity of rilpivirine pharmacokinetics with physiologically based pharmacokinetic model approach.
Journal: Drug metabolism and pharmacokinetics
Published: April 27, 2021
Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI).
Journal: Intestinal research
Published: June 30, 2020
Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies.
Journal: Intestinal research
Published: December 31, 2016
Platelet Aggregation Inhibitory Effects and Pharmacokinetics of Prasugrel Used in Combination With Aspirin in Healthy Japanese Subjects.
Journal: Clinical pharmacology in drug development
Published: May 25, 2016
Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine.
Journal: British journal of clinical pharmacology
Published: March 29, 2016
Population pharmacokinetic analysis of patritumab, a HER3 inhibitor, in subjects with advanced non-small cell lung cancer (NSCLC) or solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: July 09, 2015
Linear mixed-effects model of QTc prolongation for olmesartan medoxomil.
Journal: Journal of clinical pharmacology
Published: April 30, 2015
Last Updated: 09/26/2026